Related Experiment Video
Updated: Jul 10, 2026

Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology
Published on: March 27, 2018
Adenosine receptor heteromers and their integrative role in striatal function
Sergi Ferré1, Francisco Ciruela, César Quiroz
1National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Baltimore, MD 21224, USA.
Neurotransmitter receptors form heteromers, altering their function and acting as computational processors. Adenosine receptor heteromers, like A1-A2A, critically control neurotransmission in the central nervous system (CNS).
Area of Science:
- Neuroscience
- Molecular Pharmacology
- Cell Signaling
Background:
- Classical neurotransmission models viewed receptors as single units.
- Emerging evidence highlights the functional significance of receptor heteromerization.
Purpose of the Study:
- To review new concepts on adenosine receptor heteromers.
- To redefine classical views of central nervous system (CNS) neurotransmission.
Main Methods:
- Analysis of functional roles of adenosine receptor heteromers.
- Identification of biochemical fingerprints for receptor heteromers.
- Examination of binding characteristics and coactivation dependencies.
Main Results:
- Receptor heteromers possess distinct biochemical characteristics.
- Adenosine receptor heteromers act as computational processors modulating cell signaling.
- The adenosine A1-A2A heteromer functions as a switch controlling striatal glutamatergic neurotransmission.
- Adenosine A2A-dopamine D2 heteromers integrate neurotransmitters in striatal modules.
Conclusions:
- Neurotransmitter receptors should not be viewed as isolated units.
- Receptor heteromers are crucial for integrative roles in local neural modules.
- Heteromerization significantly impacts pre- and postsynaptic neurotransmission control.
More Related Videos
08:27Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
Published on: March 11, 2020
09:39Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
Related Concept Videos
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.